Evaluating the ototoxicity of a antiMRSA peptide KR-12-a2
Conclusion In our experiment, topically applied KR-12-a2 solution did not cause hearing loss or cochlear damage in guinea pigs. The KR-12-a2 solution can be used as ototopical drops for treating MRSA otorrhea; however, further evaluations, such as the definition of optimal concentration and combination, are necessary.
Source: Brazilian Journal of Otorhinolaryngology - Category: ENT & OMF Source Type: research
More News: Audiology | ENT & OMF | Infectious Diseases | MRSA | Otitis | Otitis Media | Pediatrics | PET Scan | Staphylococcus Aureus | Statistics | Study | Superbugs